Massachusetts Financial Services Co. MA decreased its position in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 0.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,301,347 shares of the company's stock after selling 17,985 shares during the period. Massachusetts Financial Services Co. MA owned approximately 11.38% of Qiagen worth $1,015,849,000 at the end of the most recent quarter.
Other large investors have also recently added to or reduced their stakes in the company. Groupama Asset Managment lifted its stake in Qiagen by 8,074.0% in the fourth quarter. Groupama Asset Managment now owns 31,817,740 shares of the company's stock valued at $1,416,844,000 after buying an additional 32,216,761 shares during the period. Wellington Management Group LLP grew its stake in Qiagen by 2.5% in the 4th quarter. Wellington Management Group LLP now owns 21,782,305 shares of the company's stock valued at $970,534,000 after purchasing an additional 531,362 shares during the period. Vanguard Group Inc. lifted its position in shares of Qiagen by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 8,879,089 shares of the company's stock valued at $397,937,000 after buying an additional 77,119 shares during the last quarter. Norges Bank purchased a new stake in Qiagen during the 4th quarter worth about $181,529,000. Finally, Earnest Partners LLC lifted its holdings in Qiagen by 1.6% during the 4th quarter. Earnest Partners LLC now owns 4,002,489 shares of the company's stock worth $178,231,000 after purchasing an additional 64,575 shares in the last quarter. Institutional investors own 70.00% of the company's stock.
Analyst Upgrades and Downgrades
QGEN has been the topic of several recent research reports. Redburn Atlantic cut Qiagen from a "buy" rating to a "neutral" rating in a research note on Friday, April 4th. Bank of America increased their price objective on Qiagen from $50.00 to $53.00 and gave the stock a "buy" rating in a report on Thursday, June 26th. Wall Street Zen raised Qiagen from a "buy" rating to a "strong-buy" rating in a report on Thursday, May 15th. Barclays initiated coverage on Qiagen in a report on Tuesday, June 24th. They set an "overweight" rating and a $55.00 price target on the stock. Finally, Robert W. Baird increased their target price on Qiagen from $42.00 to $43.00 and gave the company a "neutral" rating in a report on Monday, April 21st. Seven analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $49.40.
Check Out Our Latest Analysis on QGEN
Qiagen Stock Performance
Shares of QGEN traded down $0.22 during trading hours on Thursday, hitting $48.09. The company had a trading volume of 536,250 shares, compared to its average volume of 1,215,437. The firm has a market cap of $10.69 billion, a price-to-earnings ratio of 120.51, a PEG ratio of 2.41 and a beta of 0.68. The company has a quick ratio of 2.83, a current ratio of 3.37 and a debt-to-equity ratio of 0.40. The business has a fifty day moving average of $45.70 and a 200-day moving average of $42.91. Qiagen N.V. has a 12 month low of $37.63 and a 12 month high of $49.30.
Qiagen (NYSE:QGEN - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.05. Qiagen had a net margin of 4.68% and a return on equity of 14.61%. The firm had revenue of $483.46 million for the quarter, compared to the consensus estimate of $465.66 million. During the same period in the prior year, the firm posted $0.44 earnings per share. The company's revenue for the quarter was up 5.2% on a year-over-year basis. Equities analysts anticipate that Qiagen N.V. will post 2.26 EPS for the current fiscal year.
Qiagen Dividend Announcement
The business also recently declared a dividend, which was paid on Thursday, July 10th. Stockholders of record on Thursday, July 3rd were given a $0.25 dividend. This represents a dividend yield of 0.52%. The ex-dividend date was Wednesday, July 2nd. Qiagen's dividend payout ratio is presently 62.50%.
Qiagen Profile
(
Free Report)
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
Featured Articles
Before you consider QIAGEN, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and QIAGEN wasn't on the list.
While QIAGEN currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
